A Gompertzian model of human breast cancer growth
- PMID: 3191483
A Gompertzian model of human breast cancer growth
Abstract
The pattern of growth of human breast cancer is important theoretically and clinically. Speer et al. (Cancer Res., 44: 4124-4130, 1984) have recently proposed that all individual tumors initially grow with identical Gompertzian parameters, but subsequently develop kinetic heterogeneity by a random time-dependent process. This concept has elicited interest because it fits clinical data for the survival of untreated patients, for the progression of shadows on serial paired mammograms, and for time-to-relapse following mastectomy. The success of these curve-fits is compelling, and the model has been applied to clinical trials. However, the assumption of uniform nascent growth is not supported by theory or data, and individual cancers have not been shown to follow the complex growth curves predicted by the Speer model. As an alternative, if kinetic heterogeneity is understood to be an intrinsic property of neoplasia, the same three historical data sets are fit well by an unadorned Gompertzian model which is parsimonious and has many other intuitive and empirical advantages. The two models differ significantly in such clinical projections as the estimated duration of silent growth prior to diagnosis and the anticipated optimal chemotherapy schedule postsurgery.
Comment in
-
Re: Larry Norton, a Gompertzian model of human breast cancer growth.Cancer Res. 1989 Nov 15;49(22):6443-4. Cancer Res. 1989. PMID: 2627216 No abstract available.
Similar articles
-
[Kinetics of breast neoplasms].Minerva Med. 1994 Jan-Feb;85(1-2):7-16. Minerva Med. 1994. PMID: 8152580 Review. Italian.
-
A stochastic numerical model of breast cancer growth that simulates clinical data.Cancer Res. 1984 Sep;44(9):4124-30. Cancer Res. 1984. PMID: 6744323
-
Evolving concepts in the systemic drug therapy of breast cancer.Semin Oncol. 1997 Aug;24(4 Suppl 10):S10-3-S10-10. Semin Oncol. 1997. PMID: 9275000 Review.
-
Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.Br J Cancer. 2000 Jul;83(1):98-103. doi: 10.1054/bjoc.2000.1216. Br J Cancer. 2000. PMID: 10883676 Free PMC article.
-
Multicentricity in breast cancer: a submacroscopic study.Pathol Annu. 1986;21 Pt 1:143-58. Pathol Annu. 1986. PMID: 3510413 Review.
Cited by
-
Clinical opportunities and challenges in targeting tumour dormancy.Nat Rev Clin Oncol. 2013 Jan;10(1):41-51. doi: 10.1038/nrclinonc.2012.207. Epub 2012 Nov 27. Nat Rev Clin Oncol. 2013. PMID: 23183631 Review.
-
On the Role of the Objective in the Optimization of Compartmental Models for Biomedical Therapies.J Optim Theory Appl. 2020;187(2):305-335. doi: 10.1007/s10957-020-01754-2. Epub 2020 Sep 30. J Optim Theory Appl. 2020. PMID: 33012845 Free PMC article.
-
A Case of Adrenocortical Carcinoma With a Favorable Tumor Control by Radiofrequency Ablation for Liver Metastasis.J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231218135. doi: 10.1177/23247096231218135. J Investig Med High Impact Case Rep. 2023. PMID: 38105189 Free PMC article.
-
Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial.Med Oncol. 2015 Feb;32(2):334. doi: 10.1007/s12032-014-0334-8. Epub 2015 Jan 22. Med Oncol. 2015. PMID: 25609007 Clinical Trial.
-
Mathematical model approach to describe tumour response in mice after vaccine administration and its applicability to immune-stimulatory cytokine-based strategies.AAPS J. 2013 Jul;15(3):797-807. doi: 10.1208/s12248-013-9483-5. Epub 2013 Apr 19. AAPS J. 2013. PMID: 23605806 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical
Research Materials